LRRK2 and Parkinson disease: Specifically, recently described data demonstrate the increasing risk of early dementia in patients with a mutation in the SNCA gene, like SNCA triplications and the p.E46 K mutation, whereas among LRRK2-PD patients, the frequency of cognitive impairment is similar or lower than that observed in idiopathic PD.